Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-03-31 to 2022-04-11
Current total value of award: $450.64
Description: 8508993766!TYPHOID VI POLYSACC